Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 9 de 9
Filtrar
1.
Chinese Journal of Traumatology ; (6): 73-76, 2023.
Artículo en Inglés | WPRIM | ID: wpr-970978

RESUMEN

PURPOSE@#Trauma centres have been proven to provide better outcomes in developed countries for overall trauma, but there is limited literature on the systematic factors that describe any discrepancies in outcomes for trauma laparotomies in these centres. This study was conducted to examine and interrogate the effect of systematic factors on patients undergoing a trauma laparotomy in a developed country, intending to identify potential discrepancies in the outcome.@*METHODS@#This was a retrospective study of all laparotomies performed for trauma at a level 1 trauma centre in New Zealand. All adult patients who had undergone an index laparotomy for trauma between February 2012 and November 2020 were identified and laparotomies for both blunt and penetrating trauma were included. Repeat laparotomies and trauma laparotomies in children were excluded. The primary clinical outcomes reviewed included morbidity, length of hospital stay, and mortality. All statistical analysis was performed using R v.4.0.3.@*RESULTS@#During the 9-year study period, 204 trauma laparotomies were performed at Waikato hospital. The majority (83.3%) were performed during office hours (170/204), and the remaining 16.7% were performed after hours (34/204). And 61.3% were performed on a weekday (125/204), whilst 38.7% were performed on the weekend/public holiday (79/204). Most of the parameters in office hours and after hours groups had no statistically significant difference, except lactate (p = 0.026). Most of the variables in weekday and weekend groups had no statistically significant difference, except pH, lactate, length of stay, and gastrointestinal complications (p = 0.012, p < 0.001, p = 0.003, p = 0.020, respectively).@*CONCLUSION@#The current trauma system at Waikato hospital is capable of delivering care for trauma laparotomy patients with the same outcome regardless of working hours or after hours, weekday or weekend. This confirms the importance of a robust trauma system capable of responding to the sudden demands placed on it.


Asunto(s)
Adulto , Niño , Humanos , Laparotomía , Centros Traumatológicos , Estudios Retrospectivos , Nueva Zelanda/epidemiología , Ácido Láctico , Traumatismos Abdominales/cirugía
2.
Ciênc. Saúde Colet. (Impr.) ; 26(4): 1419-1428, abr. 2021. tab
Artículo en Inglés | LILACS | ID: biblio-1285924

RESUMEN

Abstract The present study was an effort to assess the mitigation interventions carried out, so far, by the nations to fight the pandemic COVID-19. The novelty of the study was that it had considered the issue of pandemic mitigation strategy as a decision making problem. The performances of the twenty nations were to be ranked. The problem considered in the study was essentially a Multi-Criteria Decision Analysis (MCDA) problem. The available alternatives were the 20 countries and the 8 traits were the criteria. The Technique of Order Preference Similarity to the Ideal Solution (TOPSIS) was used in the present study. The study used Entropy method for assignment of weights to all the criteria. The performance score obtained in respect of the countries considered in the study and the corresponding ranks indicated the relative performances of the countries in their efforts to mitigate the COVID-19 pandemic. The results show that New Zealand is the best performing country and India is the worst one. Brazil ranked 17th, while the rank of UK was 15. The performance of the USA stood at 18th position.


Resumo O presente estudo foi um esforço para avaliar as intervenções de mitigação realizadas, até o momento, pelas nações para combater a pandemia COVID-19. A novidade do estudo é que considerou a questão da estratégia de mitigação da pandemia como um problema de tomada de decisão. As performances das vinte nações deveriam ser classificadas. O problema considerado no estudo era essencialmente um problema de Análise de Decisão Multi-Critério (MCDA). As alternativas disponíveis eram os 20 países e as 8 características eram os critérios. A Técnica de Similaridade de Preferência de Pedido com a Solução Ideal (TOPSIS) foi utilizada no presente estudo. O estudo utilizou o método da Entropia para atribuição de pesos a todos os critérios. A pontuação de desempenho obtida em relação aos países considerados no estudo e as classificações correspondentes indicaram os desempenhos relativos dos países em seus esforços para mitigar a pandemia COVID-19. Os resultados mostram que a Nova Zelândia é o país com melhor desempenho e a Índia o pior. O Brasil ficou em 17º, enquanto o Reino Unido ficou em 15. O desempenho dos EUA ficou na 18ª posição.


Asunto(s)
Humanos , Pandemias/prevención & control , COVID-19/prevención & control , Estados Unidos/epidemiología , Brasil/epidemiología , Técnicas de Apoyo para la Decisión , Entropía , Reino Unido/epidemiología , India/epidemiología , Nueva Zelanda/epidemiología
3.
Epidemiol. serv. saúde ; 30(1): e2020513, 2021. tab, graf
Artículo en Inglés, Portugués | LILACS | ID: biblio-1154140

RESUMEN

Objetivo: Descrever as medidas de contenção de tipo lockdown e a incidência da COVID-19 em sete países: África do Sul, Alemanha, Brasil, Espanha, Estados Unidos, Itália e Nova Zelândia. Métodos: Estudo ecológico descritivo, com dados da incidência diária dos casos confirmados de COVID-19 entre 22 de fevereiro e 31 de agosto de 2020, e informações sobre medidas de lockdown implementadas pelo governo de cada país. Resultados: Os países que implementaram lockdown tiveram diminuição da incidência diária de COVID-19 (casos por milhão de habitantes) no período de três semanas, a contar do início da medida: África do Sul (3,7 a 1,7), Alemanha (37,5 a 33,7), Espanha (176,3 a 82,0), Itália (92,0 a 52,1) e Nova Zelândia (7,5 a 1,7). O Brasil e os Estados Unidos, que não implementaram lockdown, não apresentaram uma diminuição considerável. Conclusão: Após a implementação de lockdown, houve uma diminuição considerável do número de casos confirmados.


Objetivo: Describir las medidas de contención tipo lockdown y la incidencia de COVID-19 en los países de Sudáfrica, Alemania, Brasil, España, Estados Unidos, Italia y Nueva Zelanda. Métodos: Estudio ecológico descriptivo con datos de la incidencia diaria de los casos confirmados de COVID-19, del 22 de febrero al 31 de agosto de 2020 e informaciones sobre medidas de contención lockdown implementadas por los gobiernos de cada uno de los países. Resultados: Los países que implementaron lockdown, desde el inicio de su implementación hasta tres semanas después, tuvieron una disminución en la incidencia diaria (casos por millón de habitantes): Sudáfrica (3,7 a 1,7), Alemania (37,5 a 33,7), España (176,3 a 82,0), Italia (92,0 a 52,1) y Nueva Zelanda (7,5 a 1,7). Brasil y Estados Unidos, que no implementaron lockdown, no tuvieron una disminución considerable Conclusión: Luego de la implementación del lockdown, hubo una disminución considerable en el número de casos confirmados.


Objective: To describe lockdown-type containment measures and COVID-19 incidence in South Africa, Germany, Brazil, Spain, United States, Italy and New Zealand. Methods: This is a descriptive ecological study with data on daily incidence of confirmed COVID-19 cases from February 22 to August 31 2020, as well as information on lockdown measures implemented by the governments of each country. Results: Daily COVID-19 incidence (cases per 1 million inhabitants) decreased within three weeks after lockdown started in the countries that implemented it: South Africa (3.7 to 1.7), Germany (37.5 to 33.7) Spain (176.3 to 82.0), Italy (92.0 to 52.1) and New Zealand (7.5 to 1.7). As for Brazil and the United States, which did not implement lockdown, there was no considerable decrease. Conclusion: After lockdown implementation, there was a considerable decrease in the number of confirmed cases.


Asunto(s)
Humanos , Distancia Psicológica , Cuarentena/métodos , Control de Enfermedades Transmisibles/estadística & datos numéricos , Infecciones por Coronavirus/prevención & control , Infecciones por Coronavirus/epidemiología , Sudáfrica/epidemiología , España/epidemiología , Estados Unidos/epidemiología , Brasil/epidemiología , Incidencia , Estudios Ecológicos , Pandemias/prevención & control , Alemania/epidemiología , Política de Salud/tendencias , Italia/epidemiología , Nueva Zelanda/epidemiología
5.
Rev. panam. salud pública ; 27(4): 309-318, abr. 2010. tab
Artículo en Español | LILACS | ID: lil-548476

RESUMEN

La espectrometría de masas en tándem (MS/MS) ha posibilitado la expansión de los programas de tamizaje neonatal en diferentes países. Esta tecnología permite el diagnóstico múltiple y rápido de diversos errores innatos del metabolismo. Sin embargo, su aplicación en distintos programas en el ámbito mundial es actualmente muy heterogénea. Existen diferentes criterios para determinar si se incluye una enfermedad específica en esos programas, en algunos casos con un enfoque más restrictivo que en otros, de acuerdo con los principios tradicionales de tamizaje enunciados por Wilson y Jungner, los que habrán de ser reevaluados a la luz de esta nueva tecnología. En este trabajo se presenta una actualización sobre el uso de la MS/MS en diferentes regiones del mundo en relación con las enfermedades tamizadas y con los criterios de inclusión de nuevos problemas de salud en los programas de tamizaje neonatal.


Tandem mass spectrometry (MS/MS) has made it possible to expand neonatal screening programs in different countries. This technology permits multiple and rapid diagnosis of diverse inborn errors of metabolism. However, its use in different programs around the world currently varies widely. There are different criteria for determining whether to include a specific disease in such programs, with some cases employing a more restrictive approach than others, based on the traditional screening principles enunciated by Wilson and Jungner, which will have to be reevaluated in light of this new technology. This article presents an update on the use of MS/MS in different regions of the world in terms of the diseases screened for, and the criteria for including new health problems in neonatal screening programs.


Asunto(s)
Femenino , Humanos , Recién Nacido , Masculino , Errores Innatos del Metabolismo/diagnóstico , Tamizaje Neonatal/métodos , Espectrometría de Masas en Tándem , Américas/epidemiología , Asia/epidemiología , Australia/epidemiología , Europa (Continente)/epidemiología , Errores Innatos del Metabolismo/epidemiología , Tamizaje Neonatal/instrumentación , Tamizaje Neonatal/normas , Tamizaje Neonatal , Nueva Zelanda/epidemiología , Espectrometría de Masas en Tándem/métodos , Espectrometría de Masas en Tándem/estadística & datos numéricos
6.
Artículo en Inglés | IMSEAR | ID: sea-37911

RESUMEN

Mortality from cancer of the prostate is increasing in the Asia-Pacific, when much of this region is undergoing a transition to a Western lifestyle. The role that lifestyle factors play in prostate cancer appears limited, but existing data mainly are from the West. We conducted an individual participant data analysis of 24 cohort studies involving 320,852 men (83% in Asia). Cox proportional hazard models were used to quantify associations between risk factors and mortality from prostate cancer. There were 308 deaths from prostate cancer (14% in Asia) during 2.1 million person-years of follow-up. The age-adjusted hazard ratio (95% confidence interval; CI) for men with body mass index (BMI) 28 kg/m2 or more, compared with below 25, was 1.55 (1.12 - 2.16); no such significant relationship was found for height or waist circumference. The BMI result was unchanged after adjustment for other variables, was consistent between Asia and Australia/New Zealand (ANZ) and did not differ with age. There was no significant relationship with diabetes, glucose or total cholesterol (p > or = 0.18). Smoking, alone, showed different effects in the two regions, possibly due to the relative immaturity of the smoking epidemic in Asia. In ANZ, the multiple-adjusted hazard ratio for an extra 5 cigarettes per day was 1.12 (95%CI: 1.03 - 1.22), whereas in Asia it was 0.77 (0.56 - 1.05). Body size is an apparently important determinant of prostate cancer in the Asia-Pacific. Evidence of an adverse effect of smoking is conclusive only in the predominantly Caucasian parts of the region.


Asunto(s)
Adulto , Factores de Edad , Anciano , Australia/epidemiología , Estudios de Cohortes , Asia Oriental/epidemiología , Humanos , Masculino , Persona de Mediana Edad , Nueva Zelanda/epidemiología , Modelos de Riesgos Proporcionales , Neoplasias de la Próstata/epidemiología , Factores de Riesgo
8.
Rev. panam. salud pública ; 18(3): 163-171, set. 2005. tab
Artículo en Inglés | LILACS | ID: lil-420243

RESUMEN

OBJETIVOS: Algunos estudios epidemiológicos realizados en Estados Unidos de Amé-rica y en Europa han demostrado que la septicemia es un síndrome de muy amplia distribución cuya frecuencia ha permanecido estable o ha descendido ligeramente en los últimos decenios. El presente trabajo tiene por objetivo presentar los resultados de una revisión bibliográfica sistemática a fin de describir y caracterizar el problema de la septicemia en América Latina. MÉTODOS: Para localizar materiales sobre el tema de la septicemia en América Latina, se efectuó una búsqueda global en tres bases de datos médicas usando los términos "sepsis", "septicemia", "bacteremia", "sepsis syndrome", "epidemiology", "incidence" y "prevalence". Se abarcaron materiales en inglés, español y portugués. RESULTADOS: Se examinaron los títulos de más de 1 000 artículos de posible interés, y se revisaron detenidamente los resúmenes de más de 600 de ellos. En total se escogieron y analizaron 20 trabajos publicados entre 1990 y 2004 con gran heterogeneidad en cuanto a diseño, población, tamaño muestral, criterios de valoración y seguimiento. No en todos se aplicó la misma definición clínica de septicemia, lo cual impidió calcular con precisión la magnitud general del problema de la septicemia en América Latina. CONCLUSIONES: Según los resultados de la revisión bibliográfica, algunos estudios de carácter clínico u epidemiológico efectuados en América Latina en torno a la septicemia han sido deficientes en cuanto a diseño, población estudiada y resultado clínico evaluado. Además, hay datos que apuntan a que la septicemia y las infecciones gene-ralizadas graves podrían ser más frecuentes y acarrear mayor mortalidad en países de América Latina que en países desarrollados.


Asunto(s)
Humanos , Sepsis/epidemiología , Australia/epidemiología , Bacteriemia/epidemiología , Estudios de Cohortes , Infecciones Comunitarias Adquiridas/epidemiología , Infección Hospitalaria/epidemiología , Estudios Transversales , Determinación de Punto Final , Europa (Continente)/epidemiología , Estudios de Seguimiento , Incidencia , Unidades de Cuidados Intensivos/estadística & datos numéricos , América Latina/epidemiología , Nueva Zelanda/epidemiología , Prevalencia , Estudios Prospectivos , Proyectos de Investigación , Estudios Retrospectivos , Tamaño de la Muestra , Sepsis/clasificación , Síndrome de Respuesta Inflamatoria Sistémica/epidemiología , Terminología como Asunto , Estados Unidos/epidemiología
9.
Indian J Med Microbiol ; 2005 Apr; 23(2): 80-91
Artículo en Inglés | IMSEAR | ID: sea-53487

RESUMEN

Microsporidia are eukaryotic, spore forming obligate intracellular parasites, first recognized over 100 years ago. Microsporidia are becoming increasingly recognized as infectious pathogens causing intestinal, ocular, sinus, pulmonary, muscular and renal diseases, in both immunocompetent and immunosuppressed patients. Ocular microsporidiosis, though uncommon, could be isolated or part of systemic infections. It occurs mainly in two forms: keratoconjunctivitis form, mostly seen in immunocompromised individuals; stromal keratitis form seen in immunocompetent individuals. Recent reports indicate increasing number of cases of ocular microsporidiosis in immunocompetent individuals. The ocular cases present as superficial keratitis in AIDS patients, and these differ in presentation and clinical course from the cases seen in immunocompetent individuals which mainly appear to be as deep stromal keratitis. For most patients with infectious diseases, microbiological isolation and identification techniques offer the most rapid and specific determination of the etiologic agent, however this does not hold true for microsporidia, which are obligate intracellular parasites requiring cell culture systems for growth. Therefore, the diagnosis of microsporidiosis currently depends on morphological demonstration of the organisms themselves, either in scrapings or tissues. Although the diagnosis of microsporidiosis and identification of microsporidia by light microscopy have greatly improved during the last few years, species differentiation by these techniques is usually impossible and electron microscopy may be necessary. Immuno fluorescent-staining techniques have been developed for species differentiation of microsporidia, but the antibodies used in these procedures are available only at research laboratories at present. During the last 10 years, molecular techniques have been developed for the detection and species differentiation of microsporidia.


Asunto(s)
Américas/epidemiología , Animales , Australia/epidemiología , Cartilla de ADN , Europa (Continente)/epidemiología , Técnica del Anticuerpo Fluorescente , Humanos , India/epidemiología , Japón/epidemiología , Queratitis/diagnóstico , Queratoconjuntivitis/diagnóstico , Microscopía , Microsporidios/clasificación , Microsporidiosis/diagnóstico , Nueva Zelanda/epidemiología , Reacción en Cadena de la Polimerasa , ARN Protozoario/aislamiento & purificación , ARN Ribosómico/aislamiento & purificación , Esporas Protozoarias/aislamiento & purificación , Coloración y Etiquetado , Uganda/epidemiología , Zambia/epidemiología
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA